Team develops novel radiopharmaceutical for the diagnosis of tumor-relevant transport proteins

Radiolabeled molecules, so-called radiotracers, help nuclear physicians to detect and precisely target tumors, which often develop due to pathological changes in metabolic processes. Using positron emission tomography, a team of scientists at Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has now developed the first radiotracer labelled with the fluorine isotope 18F, which can visualize special transport proteins often found […]